Ultrasound-defined presynovitis is associated with progression to clinical arthritis in ACPA-positive individuals at risk of rheumatoid arthritis: longitudinal insights from the Karolinska Risk-RA cohort
Annals of the Rheumatic Diseases · 2026-11 · 85 (11) · 2107-2118
DOI: 10.1016/j.ard.2026.06.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-11. Verfasst von Yogan Kisten und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institute…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Anti-Citrullinated Protein Antibodies, Synovitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sweden's Innovation Agency, Swedish Research Council, Stockholms Läns Landsting.
Abstract (Originalsprache)
OBJECTIVES: This study aimed to investigate whether ultrasound (US)-detected features preceding Doppler-active synovitis are associated with progression to clinical arthritis in anticitrullinated protein antibody (ACPA)-positive individuals with musculoskeletal (MSK) symptoms. METHODS: In this prospective cohort study, 309 ACPA-positive individuals with MSK symptoms but without clinical arthritis and Doppler-active synovitis were included. US assessments evaluated minimal US findings, including synovial thickening, tendon sheath involvement, bursal effusions, and bone surface cortical irregularities. Longitudinal within-individual trajectories of US findings were analysed over time. Anticyclic citrullinated peptide 2 immunoglobulin G (IgG) and IgM rheumatoid factor (IgM RF) were measured at inclusion. The primary outcome was development of clinical arthritis over 3 years. Associations were analysed using Cox regression and logistic regression models. RESULTS: During a median follow-up of 13 months (IQR 7-22), 117 of 309 participants (38%) developed clinical arthritis, of whom 97 of 117 (83%) fulfilled the 2010 American College of Rheumatology/European League Against Rheumatism rhematoid arthritis classification criteria. Any US finding at baseline (75/309) was associated with a 3-fold increased risk of arthritis development (51/117 progressors vs 24/192 nonprogressors; hazard ratio [HR] 3.3, 95% CI 2.3-4.8). Among these, tendon sheath involvement showed the strongest association (HR 3.6, 95% CI 2.4-5.4), especially in combination with IgM RF positivity (HR 4.2, 95% CI 2.7-6.4). Longitudinal trajectories demonstrated progressive accumulation of US findings prior to arthritis onset, whereas such findings remained infrequent among nonprogressors. Tendon involvement frequently preceded synovial changes. CONCLUSIONS: Minimal US findings preceding Doppler-active synovitis, particularly tendon involvement, were strongly associated with progression to clinical arthritis in ACPA-positive individuals and support an US-identified 'presynovitis' phase of rheumatoid arthritis development and early risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Medical Unit Rheumatology, Gastro-enterology and…
- Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Center for Rheumatology, Academic Specialist Center, Stockholm Health Services, Stockholm, Sweden; Division of Clinical Epidemiology, Department o…
- Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Thermo Fisher Scientific, Uppsala, Sweden.
- Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Medical Unit Rheumatology, Gastro-enterology and Dermatology, Theme Inflammation and Ageing, Karolinska University Hospit…
Förderung
- Sweden's Innovation Agency
- Swedish Research Council
- Stockholms Läns Landsting
Zitieren
APA
Kisten, Y., Cîrciumaru, A., Dehara, M., Grönwall, C., Mathsson-Alm, L., Hansson, M., Lundberg, K., Gentline, C., Pomiano, N. V., Hensvold, A., Chatzidionysiou, K., Geschwind, S., Jakobsson, P. J., Klint, E. A., Askling, J., Westerlind, H., Rezaei, H., & Klareskog, L. (2026). Ultrasound-defined presynovitis is associated with progression to clinical arthritis in ACPA-positive individuals at risk of rheumatoid arthritis: longitudinal insights from the Karolinska Risk-RA cohort. Annals of the Rheumatic Diseases, 85(11), 2107-2118. https://doi.org/10.1016/j.ard.2026.06.022
Vancouver
Kisten Y, Cîrciumaru A, Dehara M, Grönwall C, Mathsson-Alm L, Hansson M, et al. Ultrasound-defined presynovitis is associated with progression to clinical arthritis in ACPA-positive individuals at risk of rheumatoid arthritis: longitudinal insights from the Karolinska Risk-RA cohort. Annals of the Rheumatic Diseases. 2026;85(11):2107-2118. doi:10.1016/j.ard.2026.06.022
BibTeX
@article{Kisten2026,
author = {Kisten, Yogan and Cîrciumaru, Alexandra and Dehara, Marina and Grönwall, Caroline and Mathsson-Alm, Linda and Hansson, Monika and Lundberg, Karin and Gentline, Cidem and Pomiano, Nancy Vivar and Hensvold, Aase and Chatzidionysiou, Katerina and Geschwind, Sofia and Jakobsson, Per-Johan and Klint, Erik Af and Askling, Johan and Westerlind, Helga and Rezaei, Hamed and Klareskog, Lars},
title = {Ultrasound-defined presynovitis is associated with progression to clinical arthritis in ACPA-positive individuals at risk of rheumatoid arthritis: longitudinal insights from the Karolinska Risk-RA cohort},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {11},
pages = {2107--2118},
doi = {10.1016/j.ard.2026.06.022}
}
EUVIMED